» Articles » PMID: 25749848

Non-culprit Coronary Lesions in Young Patients Have Higher Rates of Atherosclerotic Progression

Overview
Publisher Springer
Specialty Radiology
Date 2015 Mar 10
PMID 25749848
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to investigate whether non-culprit coronary lesions (NCCLs) in young patients (<45 years) who underwent percutaneous coronary intervention (PCI) with stents have higher rates of atherosclerotic progression than older patients. Eight hundred and forty-eight consecutive patients who underwent successful PCI with stents and second coronary angiography in a single center from January 7, 2008 to May 7, 2013 were enrolled. NCCL progression was assessed using three-dimensional quantitative coronary angiography and was defined as ≥ 10% diameter reduction of preexisting stenoses of ≥ 50%, ≥ 30% diameter reduction of <50% stenoses, development of a new stenosis of ≥ 30% in a previously normal segment, or progression to total occlusion. The mean time interval between two catheterization was 10.79 months; 136 (16.0%) patients exhibited progression of NCCLs. Multivariate Cox regression analysis (stepwise) showed young age to be an independent determinant of NCCL progression. Compared with the older patients(≥ 45 years), the crude hazard ratio (HR) for NCCL progression in the young patients(<45 years) was 2.17 (95% CI 1.42-3.30; P < 0.001); the association remained significant after adjustment for sex, ST elevation myocardial infarction, body mass index, systolic and diastolic blood pressure, serum lipids, fasting blood glucose, smoking, drinking, hypertension, family history of coronary heart disease, diabetes mellitus, medication use and NCCL characteristics (adjusted HR 1.70, 95% CI 1.06-2.72; P = 0.029). NCCLs in young patients (<45 years) with coronary artery disease have high rates of atherosclerotic progression.

Citing Articles

Clinical Predictors of the Rapid Progression and Revascularization of Coronary Non-Target Lesions: A Serial Angiographic Study.

Wang W, Xu H, Yuan J, Guo C, Hu F, Yang W Rev Cardiovasc Med. 2024; 25(7):251.

PMID: 39139437 PMC: 11317350. DOI: 10.31083/j.rcm2507251.


The Role of Cytokines in Cholesterol Accumulation in Cells and Atherosclerosis Progression.

Markin A, Markina Y, Bogatyreva A, Tolstik T, Chakal D, Breshenkov D Int J Mol Sci. 2023; 24(7).

PMID: 37047399 PMC: 10094347. DOI: 10.3390/ijms24076426.


Cardiovascular imaging 2015 in the International Journal of Cardiovascular Imaging.

Bezerra H, Costa R, Reiber J, Schoenhagen P, Stillman A, De Sutter J Int J Cardiovasc Imaging. 2016; 32(5):697-709.

PMID: 27086358 DOI: 10.1007/s10554-016-0877-1.

References
1.
Trzos E, Uznanska B, Rechcinski T, Krzeminska-Pakula M, Bugala M, Kurpesa M . Myocardial infarction in young people. Cardiol J. 2009; 16(4):307-11. View

2.
Doughty M, Mehta R, Bruckman D, Das S, Karavite D, Tsai T . Acute myocardial infarction in the young--The University of Michigan experience. Am Heart J. 2002; 143(1):56-62. DOI: 10.1067/mhj.2002.120300. View

3.
Goldberg R, McCormick D, Gurwitz J, Yarzebski J, Lessard D, Gore J . Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol. 1998; 82(11):1311-7. DOI: 10.1016/s0002-9149(98)00633-x. View

4.
Schoenenberger A, Radovanovic D, Stauffer J, Windecker S, Urban P, Niedermaier G . Acute coronary syndromes in young patients: presentation, treatment and outcome. Int J Cardiol. 2009; 148(3):300-4. DOI: 10.1016/j.ijcard.2009.11.009. View

5.
Waters D, LEsperance J, Gladstone P, Boccuzzi S, Cook T, Hudgin R . Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group. Circulation. 1996; 94(4):614-21. DOI: 10.1161/01.cir.94.4.614. View